3 High-Yield Pharmaceutical Stocks
The pharmaceutical industry is a natural hunting ground for reliable income stocks, since people buy drugs in good times and in bad. But which high-yield dividend stocks are actually worthy of your investment dollars? We posed that question to a team of Motley Fool healthcare investors, and they picked Pfizer (NYSE: PFE), GlaxoSmithKline (NYSE: GSK), and Novo Nordisk (NYSE: NVO).
Image source: Getty Images.
George Budwell (Pfizer): With a yield of 3.92% at present, Pfizer offers one of the richer dividends among its big pharma peer group. But the real reason to buy this dividend stock is arguably for its staying power.
Source: Fool.com
Pfizer Inc. Stock
€25.89
0.150%
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 58.36% compared to the current price of 25.89 € for Pfizer Inc..
